4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The clinical implication of minimally invasive versus open pancreatoduodenectomy for non-pancreatic periampullary cancer: a systematic review and individual patient data meta-analysis

      review-article
      1 , 2 , , 3 , 1 , 2 , 4 , 2 , 5 , 6 , 7 , 8 , 8 , 2 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 2 , 1 , , for the International Study Group on non-pancreatic periAmpullary CAncer (ISGACA)
      Langenbeck's Archives of Surgery
      Springer Berlin Heidelberg
      Minimally invasive surgery, Minimally invasive pancreatoduodenectomy, Ampulla of Vater carcinoma, Duodenal adenocarcinoma, Distal cholangiocarcinoma, Individual patient data meta-analysis

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Most studies on minimally invasive pancreatoduodenectomy (MIPD) combine patients with pancreatic and periampullary cancers even though there is substantial heterogeneity between these tumors. Therefore, this study aimed to evaluate the role of MIPD compared to open pancreatoduodenectomy (OPD) in patients with non-pancreatic periampullary cancer (NPPC).

          Methods

          A systematic review of Pubmed, Embase, and Cochrane databases was performed by two independent reviewers to identify studies comparing MIPD and OPD for NPPC (ampullary, distal cholangio, and duodenal adenocarcinoma) (01/2015–12/2021). Individual patient data were required from all identified studies. Primary outcomes were (90-day) mortality, and major morbidity (Clavien-Dindo 3a-5). Secondary outcomes were postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE), postpancreatectomy hemorrhage (PPH), blood-loss, length of hospital stay (LOS), and overall survival (OS).

          Results

          Overall, 16 studies with 1949 patients were included, combining 928 patients with ampullary, 526 with distal cholangio, and 461 with duodenal cancer. In total, 902 (46.3%) patients underwent MIPD, and 1047 (53.7%) patients underwent OPD. The rates of 90-day mortality, major morbidity, POPF, DGE, PPH, blood-loss, and length of hospital stay did not differ between MIPD and OPD. Operation time was 67 min longer in the MIPD group ( P = 0.009). A decrease in DFS for ampullary (HR 2.27, P = 0.019) and distal cholangio (HR 1.84, P = 0.025) cancer, as well as a decrease in OS for distal cholangio (HR 1.71, P = 0.045) and duodenal cancer (HR 4.59, P < 0.001) was found in the MIPD group.

          Conclusions

          This individual patient data meta-analysis of MIPD versus OPD in patients with NPPC suggests that MIPD is not inferior in terms of short-term morbidity and mortality. Several major limitations in long-term data highlight a research gap that should be studied in prospective maintained international registries or randomized studies for ampullary, distal cholangio, and duodenum cancer separately.

          Protocol registration

          PROSPERO (CRD42021277495) on the 25th of October 2021.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s00423-023-03047-4.

          Related collections

          Most cited references69

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

          Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Clavien-Dindo classification of surgical complications: five-year experience.

            The lack of consensus on how to define and grade adverse postoperative events has greatly hampered the evaluation of surgical procedures. A new classification of complications, initiated in 1992, was updated 5 years ago. It is based on the type of therapy needed to correct the complication. The principle of the classification was to be simple, reproducible, flexible, and applicable irrespective of the cultural background. The aim of the current study was to critically evaluate this classification from the perspective of its use in the literature, by assessing interobserver variability in grading complex complication scenarios and to correlate the classification grades with patients', nurses', and doctors' perception. Reports from the literature using the classification system were systematically analyzed. Next, 11 scenarios illustrating difficult cases were prepared to develop a consensus on how to rank the various complications. Third, 7 centers from different continents, having routinely used the classification, independently assessed the 11 scenarios. An agreement analysis was performed to test the accuracy and reliability of the classification. Finally, the perception of the severity was tested in patients, nurses, and physicians by presenting 30 scenarios, each illustrating a specific grade of complication. We noted a dramatic increase in the use of the classification in many fields of surgery. About half of the studies used the contracted form, whereas the rest used the full range of grading. Two-thirds of the publications avoided subjective terms such as minor or major complications. The study of 11 difficult cases among various centers revealed a high degree of agreement in identifying and ranking complications (89% agreement), and enabled a better definition of unclear situations. Each grade of complications significantly correlated with the perception by patients, nurses, and physicians (P < 0.05, Kruskal-Wallis test). This 5-year evaluation provides strong evidence that the classification is valid and applicable worldwide in many fields of surgery. No modification in the general principle of classification is warranted in view of the use in ongoing publications and trials. Subjective, inaccurate, or confusing terms such as "minor or major" should be removed from the surgical literature.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

              Matthew Page and co-authors describe PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.
                Bookmark

                Author and article information

                Contributors
                basuijterwijk@live.nl
                abuhilal9@gmail.com
                Journal
                Langenbecks Arch Surg
                Langenbecks Arch Surg
                Langenbeck's Archives of Surgery
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1435-2443
                1435-2451
                15 August 2023
                15 August 2023
                2023
                : 408
                : 1
                : 311
                Affiliations
                [1 ]GRID grid.415090.9, ISNI 0000 0004 1763 5424, Department of Surgery, , Fondazione Poliambulanza Istituto Ospedaliero, ; Brescia, Italy
                [2 ]GRID grid.7177.6, ISNI 0000000084992262, Department of Surgery, Amsterdam UMC, , Location University of Amsterdam, ; Amsterdam, the Netherlands
                [3 ]Department of Surgery, Meiwa Hospital, Hyogo, Japan
                [4 ]GRID grid.415356.0, ISNI 0000 0004 5935 6538, Department of Surgical Gastroenterology and Hepatopancreatobiliary Surgery, , GEM Hospital and Research Center, ; Ramanathapuram, Coimbatore, Tamil Nadu India
                [5 ]GRID grid.440209.b, ISNI 0000 0004 0501 8269, Department of Surgery, , OLVG, ; Amsterdam, the Netherlands
                [6 ]GRID grid.411142.3, ISNI 0000 0004 1767 8811, Hepatobiliary and Pancreatic Surgery Unit, , Hospital del Mar. Universitat Pompeu Fabra, ; Barcelona, Spain
                [7 ]GRID grid.7700.0, ISNI 0000 0001 2190 4373, Department of General, Visceral and Transplantation Surgery, , University of Heidelberg, ; Heidelberg, Germany
                [8 ]GRID grid.413967.e, ISNI 0000 0001 0842 2126, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, , University of Ulsan College of Medicine and Asan Medical Center, ; Seoul, Korea
                [9 ]GRID grid.31501.36, ISNI 0000 0004 0470 5905, Department of Surgery and Cancer Research Institute, , Seoul National University College of Medicine, ; Seoul, South Korea
                [10 ]GRID grid.15276.37, ISNI 0000 0004 1936 8091, Division of Surgical Oncology, General Surgery, , University of Florida, ; Gainesville, USA
                [11 ]GRID grid.24704.35, ISNI 0000 0004 1759 9494, Department of Surgery, , Careggi University Hospital, ; Florence, Italy
                [12 ]GRID grid.415928.3, Department of Surgery, , Misericordia Hospital of Grosseto, ; Grosseto, Italy
                [13 ]Division of Oncologic and Mini-Invasive General Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
                [14 ]GRID grid.46699.34, ISNI 0000 0004 0391 9020, Department of Liver Transplant and HPB Unit, , King’s College Hospital, ; London, UK
                [15 ]GRID grid.163555.1, ISNI 0000 0000 9486 5048, Department of Hepatopancreatobiliary and Transplant Surgery, , Singapore General Hospital, ; Singapore, Singapore
                [16 ]GRID grid.412793.a, ISNI 0000 0004 1799 5032, Department of Biliary-Pancreatic Surgery, , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, ; Wuhan, China
                Article
                3047
                10.1007/s00423-023-03047-4
                10427526
                37581763
                47dd1554-f2f8-4d35-a282-9652dffa6f15
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 April 2023
                : 3 August 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000051, National Human Genome Research Institute;
                Award ID: T32 HG0008958
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004374, Medtronic;
                Funded by: FundRef http://dx.doi.org/10.13039/100009933, Ethicon;
                Categories
                Review
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2023

                Surgery
                minimally invasive surgery,minimally invasive pancreatoduodenectomy,ampulla of vater carcinoma,duodenal adenocarcinoma,distal cholangiocarcinoma,individual patient data meta-analysis

                Comments

                Comment on this article